COVID-19

Our Advantages

ZiP Diagnostics is bringing a high sensitivity molecular test for

SARS-CoV-2, to domestic high-volume production.

The ZiP-CoVx test is a point-of-care molecular diagnostic technology that combines its test instruments and assay (swab and cartridge with reagents) manufacturing capacity.

The advantages of this system include:

Direct detection of current SARS-CoV-2 viral infection 

​

Sample type includes nasal, nasal-pharyngeal or throat swab with direct insertion into sealed cartridge (saliva sample type in development).  

​

Test result within 15 to 30 minutes with high sensitivity comparable to PCR.

​

Simple work flow

​

Low  cost test, significantly less than existing laboratory tests (order volume dependant).

Site management software provides secure, encrypted records and management of workflow, site administration, sample collection and test instruments.

​

​

​

​